Fusion Antibodies plc
Company Profile
Fusion is a Belfast based contract research organisation ("CRO") providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.
Investor Access
Fusion will host an in-person investor presentation in Belfast, Northern Ireland on Thursday, 18 September 2025.
Registered guests are welcomed from 4.15pm with the investor presentation scheduled to start at 4.30pm in Belfast City Centre.
To register to attend, please send an email to [email protected]
4.30pm Thursday, 18 September 2025
Event | Date |
Year End | 31 March |
Half Year End | 30 September |
Preliminary Results* | August |
Interim Results* | November |
AGM* | June |
* Months based on previous announcements of this kind